‘DURVIT’: A phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: Safety, toxicity and effect on the primary tumour and lymph node microenvironment

Định dạng: PDF / Số trang: 8

Nhắn tin với admin nếu không tải được